These tables present clotting factor concentrates, novel therapies, gene therapies and adjunct therapies licensed for distribution in the US for hemophilia and von Willebrand Disease. For factor concentrates, the data is presented by source material (plasma or recombinant), by class (hemophilia A, B, inhibitors, von Willebrand Disease), half-life and by manufacturer.
Bleeding disorder products and their manufacturers are in constant change, so please refer back to these tables periodically for updates. These tables may be reproduced with permission but must include the citation:
© 2026, LA Kelley Communications, Inc. All rights reserved
Click on the buttons below to download the tables as a PDF File.
